|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$83,857.17 |
2.78% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$82,096.91 |
2.73% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$77,164.60 |
2.56% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$77,173.00 |
2.56% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$73,262.07 |
2.43% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$72,097.02 |
2.39% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$71,444.65 |
2.37% |
| Waters Corporation |
WAT |
941848103 |
184 |
$70,637.60 |
2.35% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$69,841.00 |
2.32% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$69,398.32 |
2.30% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$68,936.85 |
2.29% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$68,040.03 |
2.26% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$68,208.65 |
2.26% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$68,016.38 |
2.26% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$67,642.56 |
2.25% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$66,831.60 |
2.22% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$66,421.01 |
2.21% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$63,541.88 |
2.11% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$63,464.42 |
2.11% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$63,345.76 |
2.10% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$63,074.76 |
2.09% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$62,477.10 |
2.07% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$62,300.91 |
2.07% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$61,705.50 |
2.05% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$61,685.26 |
2.05% |
| Steris Plc |
STE |
G8473T100 |
265 |
$61,040.10 |
2.03% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$60,609.75 |
2.01% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$60,308.40 |
2.00% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$59,704.00 |
1.98% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$59,665.68 |
1.98% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$58,730.88 |
1.95% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$58,190.51 |
1.93% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$57,113.23 |
1.90% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,958.22 |
1.89% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$56,064.65 |
1.86% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$54,488.68 |
1.81% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$53,911.68 |
1.79% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$52,906.24 |
1.76% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$52,582.20 |
1.75% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$52,538.16 |
1.74% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$52,128.39 |
1.73% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$51,736.77 |
1.72% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$50,241.00 |
1.67% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$47,629.02 |
1.58% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$47,034.00 |
1.56% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$43,987.30 |
1.46% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$43,436.28 |
1.44% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$42,494.67 |
1.41% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$40,473.18 |
1.34% |
| US Dollar |
$USD |
|
14,909 |
$14,908.88 |
0.50% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|